In an exciting collaboration with our colleagues from the group of Prof. Theodore Jardetzky (Stanford University), we have published findings detailling the modes-of-action of the novel therapeutic anti-IgE antibody Ligelizumab in Nature Communications. Congratulations to both first authors, Pascal and Svetlana and to everyone involved in the study. The article is open access - so, feel free to check it out!